 |
The Biomedical & Life Sciences Collection
New Releases for October
|
|
|
This month’s release to The Biomedical & Life Sciences Collection features talks by academic and industry experts on bladder cancer, growth screening, early evolution of animals, vitamins & minerals, and much more.
Published within the Periodic Reports: Advances in Clinical Interventions and Research Platforms series, is the talk ‘Digital health technologies (DHTs) for drug development in CNS diseases’. In this talk, Dr. Diane T. Stephenson, Vice President of Neurology at the Critical Path Institute (USA), discusses how DHTs could significantly improve the development of treatments for neurodegenerative diseases, particularly by enabling earlier detection and more meaningful measurement of disease progression. Dr. Stephenson also emphasises the importance of collaboration between researchers, industry, regulators and patients, rather than individual organisations developing tools independently.
Kind regards,
The Editorial Team
|
|
|
|
New in Vitamins and Minerals Your Body Needs
|
|
|
Phosphorus
Prof. Susan Fairweather-Tait
University of East Anglia, UK
|
|
|
|
|
|
Zinc
Prof. Susan Fairweather-Tait
University of East Anglia, UK
|
|
|
|
|
|
Cobalamin (vitamin B12)
Prof. Susan Fairweather-Tait
University of East Anglia, UK
|
|
|
|
|
More New Releases
|
|
|
Digital health technologies (DHTs) for drug development in CNS diseases
Dr. Diane T. Stephenson
Critical Path Institute, USA
|
|
|
|
|
|
Early evolution of animals: a paleontological perspective
Prof. Shuhai Xiao
Virginia Tech, USA
|
|
|
|
|
|
Biomedicines: extraordinary opportunities amidst uncertain times
Prof. Michael Kinch
Stony Brook University, USA
|
|
|
|
|
|
The evolving landscape of sepsis: from empiricism to precision medicine
Prof. Ignacio Martin-Loeches
Trinity College Dublin, Ireland
|
|
|
|
|
|
Walking on water: load bearing, joint perfusion and osteoarthritis
Dr. Michael Beverly
University of Oxford, UK
|
|
|
|
|
|
Bladder cancer: types, risk factors, diagnosis, treatment and prevention: introduction to bladder cancer
Prof. Guru P. Sonpavde
AdventHealth Cancer Institute, USA
|
|
|
|
|
|
Bladder cancer: types, risk factors, diagnosis, treatment and prevention: further clinical trials
Prof. Guru P. Sonpavde
AdventHealth Cancer Institute, USA
|
|
|
|
|
|
Routine growth screening: does it measure up?
Prof. Natasha Shur
The George Washington University, USA
|
|
|
|
|
|
Growth screening and rare disease
Prof. Natasha Shur
The George Washington University, USA
|
|
|
|
|
|
Itch vs. pain
Prof. Ru-Rong Ji
Duke University Medical Center, USA
|
|
|
|
|
|
ICH S12: nonclinical biodistribution considerations for gene therapy products
Dr. Tineke van den Hoorn
Dutch Medicine Evaluation Board, The Netherlands
|
|
|
|
|
|
U.S. privacy law and digital therapeutics
Ms. Lucia C. Savage
CEO, Savage Healthcare Strategies, USA
|
|
|
|
|
New Interviews
|
|
|
Risdiplam for prenatal therapy of spinal muscular atrophy
Dr. Richard Finkel
St. Jude Children's Research Hospital, USA
|
|
|
|
|
|
Lariocidin: a novel antibiotic that disrupts bacterial protein synthesis
Prof. Gerry Wright
McMaster University, Canada
|
|
|
|
|
|
Newborn screening: how genome sequencing is changing early diagnosis
Dr. Wendy Chung
Harvard Medical School, USA
|
|
|
|
|
|
The case of an asymptomatic Alzheimer’s mutation carrier
Dr. Jorge J. Llibre-Guerra
Washington University in St. Louis, USA
|
|
|
|
|
Featured talks from previous releases
|
|
|
|
|
|
|
|
For assistance, contact HSTalks subscriber support:
Subscriber Support, Henry Stewart Talks Ltd
Tel: +44 (0) 20 7092 3480, Email: access@hstalks.com
|
|
For more specially commissioned lectures:
|
